August 23, 2023
Two psychiatrists at Dalhousie University and the Nova Scotia Health Authority (NSHA) have plans to apply genomics to the development of some much-needed clinical tools for the early detection and treatment of bipolar disorder. Success could bring significant improvement to the lives of those with the condition.
Sign up for our free newsletter.
We will deliver SEQUENCE to your inbox. SEQUENCE highlights the latest genomics applications and research initiatives in Atlantic Canada. Subscribe to stay informed.
We will deliver SEQUENCE to your inbox. SEQUENCE highlights the latest genomics applications and research initiatives in Atlantic Canada. Subscribe to stay informed.
PRevious Issues
Genome Atlantic gratefully acknowledges the financial support of the Government of Canada through Genome Canada, as well as the Atlantic Canada Opportunities Agency and the provincial governments of Newfoundland and Labrador, Nova Scotia, New Brunswick, and Prince Edward Island.
Genome Atlantic is one of 7 Genome Centres in Canada that are part of the Genome Canada Enterprise. This network encourages collaboration, with each centre focusing on the needs of their respective regions.
Site Navigation
